中国临床保健杂志
中國臨床保健雜誌
중국림상보건잡지
CHINESE JOURNAL OF CLINICAL HEALTHCARE
2014年
5期
505-507
,共3页
赵江萍%陈海龙%王凤鸣
趙江萍%陳海龍%王鳳鳴
조강평%진해룡%왕봉명
糖尿病,2 型%抗原,CD28%T 淋巴细胞
糖尿病,2 型%抗原,CD28%T 淋巴細胞
당뇨병,2 형%항원,CD28%T 림파세포
Diabetes Mellitus,Type 2%Antigens,CD28%T-Lymphocytes
目的:分析2型糖尿病患者外周血中膜型及可溶性 CD28分子的表达及其意义。方法分别收集2012年12月至2013年12月在北京军区联勤部门诊部就诊的30例2型糖尿病患者(糖尿病组)及同期30名健康体检者(对照组)的外周血,通过溶血及流式细胞术检测其外周血 T 细胞表面 CD28分子的表达,酶联免疫吸附(ELISA)法检测血清中可溶性 CD28的水平,并进行对比分析。结果糖尿病组外周血 CD4+CD28+T 细胞和 CD8+CD28+T 细胞显著低于对照组[(28.29±7.71)%比(32.77±4.28)%和(12.18±3.17)%比(18.53±3.27)%,均 P <0.01],血清中可溶性 CD28水平显著高于对照组[(2.86±0.96)比(0.61±0.19)μg/L,P <0.01]。结论协同刺激分子 CD28很可能参与了2型糖尿病的免疫病理机制。
目的:分析2型糖尿病患者外週血中膜型及可溶性 CD28分子的錶達及其意義。方法分彆收集2012年12月至2013年12月在北京軍區聯勤部門診部就診的30例2型糖尿病患者(糖尿病組)及同期30名健康體檢者(對照組)的外週血,通過溶血及流式細胞術檢測其外週血 T 細胞錶麵 CD28分子的錶達,酶聯免疫吸附(ELISA)法檢測血清中可溶性 CD28的水平,併進行對比分析。結果糖尿病組外週血 CD4+CD28+T 細胞和 CD8+CD28+T 細胞顯著低于對照組[(28.29±7.71)%比(32.77±4.28)%和(12.18±3.17)%比(18.53±3.27)%,均 P <0.01],血清中可溶性 CD28水平顯著高于對照組[(2.86±0.96)比(0.61±0.19)μg/L,P <0.01]。結論協同刺激分子 CD28很可能參與瞭2型糖尿病的免疫病理機製。
목적:분석2형당뇨병환자외주혈중막형급가용성 CD28분자적표체급기의의。방법분별수집2012년12월지2013년12월재북경군구련근부문진부취진적30례2형당뇨병환자(당뇨병조)급동기30명건강체검자(대조조)적외주혈,통과용혈급류식세포술검측기외주혈 T 세포표면 CD28분자적표체,매련면역흡부(ELISA)법검측혈청중가용성 CD28적수평,병진행대비분석。결과당뇨병조외주혈 CD4+CD28+T 세포화 CD8+CD28+T 세포현저저우대조조[(28.29±7.71)%비(32.77±4.28)%화(12.18±3.17)%비(18.53±3.27)%,균 P <0.01],혈청중가용성 CD28수평현저고우대조조[(2.86±0.96)비(0.61±0.19)μg/L,P <0.01]。결론협동자격분자 CD28흔가능삼여료2형당뇨병적면역병리궤제。
Objective To analyze the expression of membrane type CD28 and soluble CD28 in peripheral blood of type 2 diabetes patients.Methods The peripheral blood mononuclear cells (PBMCs)of 30 subjects with type 2 diabetes (diabetes group)and 30 healthy donors (control group)were collected from December 201 2 to De-cember 201 3 in the out -patient department of Outreach Logistics Department of Beijing Military Region.The expres-sion of CD28 on T cells in peripheral blood of type 2 diabetes patients was detected by flow cytometry (FCM).The secretion of soluble CD28 in serum was detected using the skills of Enzyme -linked immunosorbent assay (ELISA). The data was analyzed by the Graphpad Prism 5.01 program.Results The percentage of CD4 +CD28 +and CD8+CD28 +T cells in peripheral blood of type 2 diabetes patients were (28.29 ±7.71 )% and (1 2.1 8 ±3.1 7)% re-spectively,and were decreased markedly compared with healthy control (32.77 ±4.28% and 1 8.53 ±3.27%,P <0.01 and P <0.001 ).Compared with control,the level of soluble CD28 was increased significantly in serum of type 2 diabetes patients ((2.86 ±0.96)vs (0.61 ±0.1 9)μg/L,P <0.001 ).Conclusion The costimulatory mole-cule CD28 maybe take part in the immunological pathogenesis of type 2 diabetes.